Nebuhaler versus wet aerosol for domiciliary bronchodilator therapy: A multi‐centre clinical comparison

Abstract

MDI terbutaline delivered via Nebuhaler provides clinical benefit similar to that of wet aerosol terbutaline in the long-term domiciliary management of patients with stable airflow obstruction.